SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SPON ADS NEW
Total 13F shares
241,795
Share change
+241,795
Total reported value
$715,888
Price per share
$2.96
Number of holders
9
Value change
+$715,888
Number of buys
9

Quarterly Holders Quick Answers

What is CUSIP 09073Q204?
CUSIP 09073Q204 identifies SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) as of Q4 2022

As of 31 Dec 2022, SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 241,795 shares. The largest 9 holders included SABBY MANAGEMENT, LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, Credit Agricole S A, UBS Group AG, Aspire Private Capital, LLC, Global Retirement Partners, LLC, WELLS FARGO & COMPANY/MN, and NewSquare Capital LLC. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.